Huons Global Co., Ltd. (084110) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Huons Global Co., Ltd. (084110:KRX), powered by AI.

Current Price
₩66,800
P/E Ratio
31.6
Market Cap
845.7B
Sector
Common Stock
What is the Huons Global Co., Ltd. stock price forecast?

Huons Global Co., Ltd. is currently trading at ₩66,800. View real-time AI analysis on Alpha Lenz.

What is Huons Global Co., Ltd. insider trading activity?

View the latest insider trading data for Huons Global Co., Ltd. on Alpha Lenz.

What is Huons Global Co., Ltd.'s P/E ratio?

Huons Global Co., Ltd.'s P/E ratio is 31.6.

Huons Global Co., Ltd.

KRX · 084110
₩66,800
Ask about Huons Global Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Huons Global Co., Ltd. trades at a P/E of 31.6 (premium valuation) with modest ROE of 5.0%. 3Y revenue CAGR of 12.3% highlights clear growth momentum.

Ask for details

Company Overview

Huons Global Co., Ltd. is a prominent player in the pharmaceutical and healthcare industry, engaging primarily in the production and distribution of comprehensive pharmaceutical solutions. The company focuses on developing high-quality medicines and healthcare products that address a range of medical needs, reinforcing its commitment to improving patient care and health outcomes globally. Huons Global is involved in the manufacturing of prescription drugs, over-the-counter (OTC) medications, and specialized medical devices, positioning itself as a versatile entity in the healthcare sector. With its headquarters in South Korea, Huons Global leverages significant expertise in research and development, emphasizing innovation and technology to create products that meet international standards. Its environment respects and adheres to stringent quality assurance protocols, ensuring top-tier product safety and efficacy. The company's influence extends into multiple sectors, including hospital pharmacies, private healthcare providers, and retail pharmaceutical outlets. As a key contributor to the healthcare market, Huons Global upholds a strategic role in addressing both transient and chronic conditions, bolstering its standing in the global context of healthcare production and distribution.

CEOSong Soo-young, Yoon Sung-Tae (Independent representation)
SectorCommon Stock
IndustryCommon Stock
0

Company Statistics

FY 2024

Profile

₩845,675,441,600Market Cap
₩813,460,515,140Revenue
12.66MShares Out
0Employees

Margins

51.68%Gross
18.63%EBITDA
11.97%Operating
11.11%Pre-Tax
8.25%Net

Valuation

31.62P/E
1.57P/B
1.00EV/Sales
8.64EV/EBITDA
-23.21P/FCF

Growth (CAGR)

12.28%Rev 3Yr
12.60%Rev 5Yr
8.56%Op Inc 3Yr
5.96%Op Inc 5Yr
27.92%Net Inc 3Yr
3.20%Net Inc 5Yr

Returns

4.93%ROA
5.05%ROE
7.40%ROIC

Financial Health

₩247,333,180,960Cash & Cash Equivalents
₩194,450,717,830Net Debt
45.82%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Huons Global Co., Ltd. (ticker: 084110) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $845.7B.

The current price is ₩66,800 with a P/E ratio of 31.62x and P/B of 1.57x.

ROE is 5.05% and operating margin is 11.97%. Annual revenue is $813.5B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Huons Global Co., Ltd. (Common Stock) Stock Forecast & Analysis ₩66,800 | Alpha Lenz